ACOG earnings date and last-quarter result: next report 2026-08-13, last quarter beat, P/E -5.89. Updated 2026-07-23.
Alpha Cognition (ACOG) Research Hub
Alpha Cognition (ACOG) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 8.3 USD (-0.48%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -5.89, market cap 0.12B. This hub links to the full technical, earnings and options research available for ACOG.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 8.3 USD (-0.48%) |
| 52-week range | 5.85 USD – 10.1 USD |
| Trend regime | Range |
| 14-day RSI | 30 (Oversold) |
| Trailing P/E | -5.89 |
| Market cap | 0.12B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for ACOG
Covered Call on ACOG: how it works, illustrative setup around the real 8.3 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ACOG: how it works, illustrative setup around the real 8.3 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ACOG: how it works, illustrative setup around the real 8.3 USD price, max profit/loss, breakeven and when to use it. Educational.
ACOG technical analysis: range, last 8.3 USD, RSI 30, 52w range 5.85 USD–10.1 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ACOG in?
Alpha Cognition (ACOG) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ACOG in an uptrend or downtrend?
As of 2026-10-26, ACOG is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ACOG's trailing P/E ratio?
ACOG's trailing P/E is -5.89, with a market cap of 0.12B. See the earnings research page for full valuation detail.
When does ACOG next report earnings?
ACOG is next scheduled to report earnings on 2026-08-13.